0 votes
asked ago by (9.1k points)
Jan 26 -- The Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled National Notifiable Diseases Surveillance System (NNDSS) to the Office of Management and Budget (OMB) for review and approval and invites public comments by February 25, 2021.
The NNDSS is based on data collected at the state, territorial and local levels as a result of legislation and regulations in those jurisdictions that require health care providers, medical laboratories, and other entities to submit health-related data on reportable conditions to public health departments. These reportable conditions, which include infectious and non-infectious diseases, vary by jurisdiction depending upon each jurisdiction's health priorities and needs. Each year, the Council of State and Territorial Epidemiologists (CSTE), supported by CDC, determines which reportable conditions should be designated nationally notifiable or under standardized surveillance.

CDC requests a three-year approval for a Revision for the NNDSS. This Revision includes requests for approval to: (1) Receive case notification data for Multisystem Inflammatory Syndrome (MIS) associated with Coronavirus Disease 2019 (COVID-19); (2) receive new disease-specific data elements for Anthrax, Brucellosis, Campylobacteriosis, Cholera, Cryptosporidiosis, Hansen's Disease, Leptospirosis, Melioidosis, MIS associated with COVID-19, COVID-19, S. Paratyphi Infection, S. Typhi Infection, Salmonellosis, STEC, Shigellosis, and Vibriosis; and (3) Receive new vaccine-related data elements for all conditions.

The NNDSS currently facilitates the submission and aggregation of case notification data voluntarily submitted to CDC from 60 jurisdictions: Public health departments in every U.S. state, New York City, Washington DC, five U.S. territories (American Samoa, the Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and the U.S. Virgin Islands), and three freely associated states (Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). This information is shared across jurisdictional boundaries and both surveillance and prevention and control activities are coordinated at regional and national levels.
NNDSS website: https://wwwn.cdc.gov/nndss/
NNDSS submission to OMB: https://www.reginfo.gov/public/do/PRAViewICR?ref_nbr=202101-0920-007  Click on IC List for forms, View Supporting Statement for narrative on purpose, plans, and methods.
FR notice inviting comments: https://www.federalregister.gov/documents/2021/01/26/2021-01619/agency-forms-undergoing-paperwork-reduction-act-review
Point of contact: Umed A. Ajani, Associate Director for Science, Division of Health Informatics and Surveillance, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention 404-498-0258 UAjani@cdc.gov   
For AEA members wishing to submit comments to OMB, "A Primer on How to Respond to Calls for Comment on Federal Data Collections" is available at https://www.aeaweb.org/content/file?id=5806

Please log in or register to answer this question.